Thuja Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Thuja Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 8, 2025	Pan Cancer T	$11.7M Grant / Other Equity	—	Dutch Ministry of Economic Affairs, Erasmus MC O&O Holdings, InnovationQuarter, Michel Briejer, Van Herk Ventures
May 26, 2025	Salvia BioElectronics	$60.0M Series B	Caaj Greebe	BOM, Dolby Family Ventures, EIC Fund, INKEF Capital, Panakes Partners, SHS Gesellschaft für Beteiligungsmanagement
Jul 11, 2024	Pan Cancer T	$4.6M Seed Extension	Kees Recourt	Erasmus MC O&O Holdings, Swanbridge Capital, Van Herk Ventures
Jun 11, 2024	Tacalyx GmbH	$15.1M Seed Extension	Thuja Capital	—
Nov 1, 2023	Artica Therapeutics	$13.0M Seed	Seroba Life Sciences, Michel Briejer	OrbiMed, Heather Preston, BioGeneration Ventures, InnovationQuarter
Sep 1, 2023	Gradient Denervation Technologies	$15.0M Series A	Asabys Partners	Soffinova Partners, Evan Castiglia
Nov 1, 2022	FundaMental Pharma	$10.0M Seed	BGV (BioGeneration Ventures), Michel Briejer	INKEF Capital, Johnson & Johnson Innovation, Hakan Goker, Niels Sharman
Aug 25, 2022	AstriVax	$29.9M Seed	Caroline Goddeeris, Shelley Margetson	Ackermans & van Haaren, BNP Paribas Fortis Private Equity, Flanders Future Tech Fund, KU Leuven, Merieux Equity Partners
Mar 1, 2022	InnoSIGN	$8.0M Series A	—	Life Science Angels, BOM, Casdin Capital
Dec 16, 2021	Synerkine Pharma	$4.0M Series A Extension	Ted Fjällman	Utrecht Holdings
Sep 30, 2021	EsoBiotec	$7.0M Pre-Series A	—	Helena Pozios, Franssen Christina, Michel Briejer, Walloon Region
Sep 22, 2020	Salvia BioElectronics	$30.5M Grant / Series A	Roel Bulthuis, Diana Saraceni, Sascha Alilovic	BOM, Dolby Family Ventures, Netherlands Enterprise Agency
Sep 7, 2020	NutriLeads	$7.7M Series B	—	Goeie Grutten Impact Fonds, Nityen Lal, Oost NL, SHIFT Invest
Mar 25, 2019	Synerkine Pharma	$3.7M Series A	Thuja Capital	—
Jul 1, 2016	Nightbalance	$14.0M Series B	Dirk Kersten	Forbion, Health Innovation Fund, Van Herk Ventures
Dec 1, 2011	argenx	$37.1M Series B	Michael B. Sheffery, Isabelle de Cremoux	BioGeneration Ventures, Credit Agricole Private Equity, Erasmus Biomedical Fund, Forbion, LSP, VIB
Sep 10, 2009	argenx	$13.8M Series A	Forbion, LSP	BioGeneration Ventures, Erasmus MC O&O Holdings, KBC